Insider trading · Q3 2026 · CIK 30625

Flowserve Corp (FLS) insider trading.

In Q3 2026, insiders at Flowserve Corp reported 6 non-derivative transactions on 9 Forms 3, 4 and 5: 0 open-market purchases and 0 sales.

Transactions
6
Purchases (P)
0
Sales (S)
0
Net shares, P minus S
0
Insiders
3
Last filed
2026-09-23

Insiders

InsiderRelationshipTransactionsBuysSales
Hudson Susan ClaireOfficer · Chief Legal Officer300
Klopfer Matthew CarlOfficer · President, FPD200
Rowe Robert ScottDirector, Officer · President & CEO100

Transactions

6 non-derivative rows, newest transaction first. Shares and prices as filed.
DateInsiderCodeSharesPriceOwned afterFiling
2026-09-23Klopfer Matthew CarlM (A)3,049$09,894Form 4
2026-09-23Klopfer Matthew CarlF (D)1,200$74.678,694Form 4
2026-09-01Hudson Susan ClaireA (A)31$79.0924,889Form 4
2026-08-03Hudson Susan ClaireA (A)48$75.9924,858Form 4
2026-07-01Hudson Susan ClaireA (A)33$74.1624,810Form 4
2026-07-01Rowe Robert ScottA (A)60$74.16507,835Form 4

Transaction codes in this quarter

Get FLS insider transactions through the API

Request with your API key
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=30625&limit=100" \
  -H "Authorization: Bearer $SEC_API_KEY"

Insider trading API guide · FLS company page · Flowserve Corp on SEC.gov

Questions

Are insiders buying or selling Flowserve Corp (FLS)?

In Q3 2026, insiders at Flowserve Corp reported 6 non-derivative transactions on 9 Forms 3, 4 and 5: 0 open-market purchases and 0 sales. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.

Where do these Flowserve Corp insider trades come from?

From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.

Source: SEC Insider Transactions Data Sets, Q3 2026, retrieved 2026-10-27. Footnotes, derivative holdings and amendments are in the linked filings. Not investment advice.

Plain-text version for agents and LLMs: /insider-trading/fls.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.